Imaging subtypes reveal distinct biological substrates and disability profiles in multiple sclerosis

Clicks: 2
ID: 329696
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #401 of 406 articles by views in Brain research

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 406 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Multiple sclerosis is characterized by marked biological heterogeneity that is only partly captured by conventional clinical phenotypes and age-at-onset categories. MRI can detect focal lesions, diffuse microstructural damage and atrophy, but these measures are usually considered separately. We therefore aimed to use Subtype and Stage Inference (SuStaIn), an unsupervised machine learning framework, to identify biologically meaningful MRI subtypes of multiple sclerosis and determine their associations with disability, age at onset, cognition, genetic susceptibility to more severe disease, and relapse-independent progression. We applied SuStaIn to multimodal 3T brain MRI data from 1017 multiple sclerosis patients and 548 healthy controls. Imaging features included T2-hyperintense white matter lesion volume, mean diffusivity in white matter lesions and major white matter tracts, and cortical and deep gray matter volumes. Cognitive testing was available in 501 patients, genetic profiling in 650, and longitudinal clinical follow-up in 645 (median follow-up=6.57 years). An independent validation cohort included 247 multiple sclerosis patients and 141 healthy controls. SuStaIn identified four MRI subtypes: lesion-led (44%), cortex-led (23%), tract-led (23%), and deep gray matter/cerebellar-led (10%). Cortex-led and deep gray matter/cerebellar-led subtypes were enriched in progressive disease (47% and 56%), whereas lesion-led and tract-led subtypes were predominantly relapsing-remitting disease (66% and 71%) (p<0.001). Tract-led subtype was overrepresented in pediatric-onset disease (38%) and underrepresented in adult-onset disease (19%); lesion-led subtype predominated in adult-onset disease (48%), and deep gray matter/cerebellar-led subtype was more frequent in late-onset disease (14%) (p<0.001). Expanded Disability Status Scale scores ≥4.0 and ≥6.0 were more frequent in cortex-led and deep gray matter/cerebellar-led disease than in lesion-led or tract-led disease (45.3% and 55.6% versus 34.3% and 31.9%, and 27.8% and 29.3% versus 20.0% and 18.7%; p<0.001). Relapse-independent progression-free survival differed across subtypes (p=0.04) and was 1.67 and 1.93 years shorter in cortex-led and deep gray matter/cerebellar-led disease, respectively, than in lesion-led disease (p<0.001). Cognitive performance and genetic risk scores for multiple sclerosis severity did not differ across subtypes, but within each subtype advancing SuStaIn stage was associated with worse global and domain-specific cognitive performance (all p≤0.030). The four-subtype structure was reproduced in the independent validation cohort. Multimodal MRI analysed with SuStaIn identified reproducible subtypes of multiple sclerosis with clinically meaningful differences in phenotype, age at onset, disability, and relapse-independent progression, while cognitive impairment was related to advancing SuStaIn stage within each subtype. This framework may support biologically informed patient stratification and more mechanism-based prognostic and therapeutic approaches in multiple sclerosis.
Reference Key
openalex_W7214095970 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Paolo Preziosa, Loredana Storelli, Ferdinando Clarelli, Elisabetta Pagani, Nicolò Tedone, Monica Margoni, Federica Esposito, Antonio Gallo, Alessandro d'Ambrosio, Massimo Filippi, Maria A Rocca
Journal Brain research
Year 2026
DOI
10.1093/brain/awag320
URL
https://doi.org/10.1093/brain/awag320
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.